PRESS RELEASE published on 05/16/2025 at 18:30, 1 year 2 months ago Information relative au nombre total de droits de vote et d'actions composant le capital social Néovacs communique le nombre d'actions et de droits de vote composant son capital social conformément aux régulations. La société développe des thérapies pour des maladies inflammatoires et auto-immunes Droits De Vote Capital Social Biopharmaceutique Néovacs Thérapies
BRIEF published on 05/06/2025 at 20:05, 1 year 3 months ago Capital reduction at Neovacs Capital Reduction Investor Caution Dilutive Financing Nominal Value Stock Market Pressure
BRIEF published on 05/06/2025 at 20:05, 1 year 3 months ago Réduction du capital chez Néovacs Valeur Nominale Réduction Capital Financements Dilutifs Pression Boursière Prudence Investisseur
PRESS RELEASE published on 05/06/2025 at 20:00, 1 year 3 months ago Ajustement de la valeur nominale Réduction de capital pour Néovacs, société biopharmaceutique, suite à résolution votée en AG. Focus sur thérapies pour maladies inflammatoires et auto-immunes Biopharmaceutique Réduction De Capital Maladies Inflammatoires Néovacs Thérapies
BRIEF published on 05/06/2025 at 08:05, 1 year 3 months ago Neovacs: 2024 Annual Results and Outlook Financial Results Funding MRNA Vaccine Pharnext Néovacs
BRIEF published on 05/06/2025 at 08:05, 1 year 3 months ago Néovacs : Résultats annuels 2024 et perspectives Résultats Financiers Financement Pharnext Néovacs Vaccin ARNm
PRESS RELEASE published on 05/06/2025 at 08:00, 1 year 3 months ago Résultats annuels 2024 Néovacs annonce des avancées dans le développement de vaccins ARNm contre les allergies, avec une valorisation par un cabinet indépendant. La société présente ses résultats annuels 2024 et son point sur le financement ainsi que le récentrage du portefeuille de participations et de l'investissement dans Pharnext Financement Résultats Annuels Néovacs Allergies Vaccin ARNm
BRIEF published on 05/05/2025 at 12:05, 1 year 3 months ago Néovacs réalise une levée de fonds de 1,2 million d'euros Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
BRIEF published on 05/05/2025 at 12:05, 1 year 3 months ago Neovacs raises 1.2 million euros in fundraising Biotechnology Fundraising Investment Dilution OCEANE-BSA
PRESS RELEASE published on 05/05/2025 at 12:00, 1 year 3 months ago Levée de fonds de 1,2 MEUR Néovacs annonce une levée de fonds de 1,2 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
Published on 08/11/2026 at 12:10, 42 minutes ago CoTec Holdings Corp. Announces $20m Private Placement Of Unsecured Convertible Debentures
Published on 08/11/2026 at 12:00, 52 minutes ago Bitterroot Resources Ltd. - Update on the LM Nickel-Copper Project, Michigan, USA
Published on 08/11/2026 at 12:00, 52 minutes ago Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
Published on 08/11/2026 at 07:00, 5 hours 52 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 12 hours 12 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 12:40, 12 minutes ago Green Street Launches Its MCP Server, Powered by GreenStreetAI™, Connecting CRE Intelligence Directly to Corporate Instances of Claude, ChatGPT, Gemini, and Other AI Platforms
Published on 08/11/2026 at 12:30, 22 minutes ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Published on 08/11/2026 at 12:05, 47 minutes ago Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility
Published on 08/11/2026 at 12:00, 52 minutes ago Iute Advances Its Digital Banking Platform with iuteMarket
Published on 08/10/2026 at 18:00, 18 hours 52 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 18 hours 52 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 19 hours 7 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026